Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 23 June 2025 - 15:33

Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)

Submitted by Anonymous (not verified) on 23 June 2025 - 14:27

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2025, Online, from 20 October 2025, 09:00 (CEST) to 22 October 2025, 13:30 (CEST)

Submitted by Anonymous (not verified) on 23 June 2025 - 14:26

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2025, Online, from 20 October 2025, 09:00 (CEST) to 22 October 2025, 13:30 (CEST)

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2025, Online, from 17 September 2025, 14:00 (CEST) to 19 September 2025, 18:30 (CEST)

Submitted by Anonymous (not verified) on 23 June 2025 - 14:25

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - September 2025, Online, from 17 September 2025, 14:00 (CEST) to 19 September 2025, 18:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More